BACKGROUND: We aimed to characterize seminal hepatitis C virus (HCV) RNA dynamics in human immunodeficiency virus (HIV)-positive men with acute HCV infection given its potential role in sexual transmission of HCV. METHODS: Men with acute HCV infection (duration, ≤12 months) or chronic HCV infection (duration, >12 months) were prospectively recruited. Paired semen and blood samples were assayed for HCV RNA levels. Results were analyzed using χ(2), Fisher exact, Mann-Whitney U, and Kruskal-Wallis tests. RESULTS: Eighteen men (27.3%) had acute HCV and HIV coinfection, 22 (33.3%) had chronic HCV infection and HIV coinfection, and 26 (39.4%) had chronic HCV monoinfection. HCV RNA was detected in semen specimens from 29 of 66 men (43.9%). The median HCV RNA level in blood was 4.0 log IU/mL higher than that in semen. HCV RNA levels were correlated in semen and blood (r(2) = 0.142). Neither HIV positivity nor acute HCV infection was associated with an increased frequency of seminal HCV RNA detection. Among men with acute HCV and HIV coinfection, the median HCV RNA level in blood specimens from those with seminal HCV RNA was higher than that in blood specimens from those without seminal HCV RNA (P = .001). Seminal HCV RNA was detected in ≥1 sample for 26 of 35 men (74.3%) attending follow up. CONCLUSIONS: HCV RNA was detected in semen during both acute and chronic HCV infection. This was unaffected by HIV positivity or the phase of HCV infection. Elevated seminal HCV RNA levels could contribute to sexual transmission of HCV, but other factors, including high-risk behaviors, may be the main drivers for HCV transmission in HIV-infected individuals.
BACKGROUND: We aimed to characterize seminal hepatitis C virus (HCV) RNA dynamics in human immunodeficiency virus (HIV)-positive men with acute HCV infection given its potential role in sexual transmission of HCV. METHODS:Men with acute HCV infection (duration, ≤12 months) or chronic HCV infection (duration, >12 months) were prospectively recruited. Paired semen and blood samples were assayed for HCV RNA levels. Results were analyzed using χ(2), Fisher exact, Mann-Whitney U, and Kruskal-Wallis tests. RESULTS: Eighteen men (27.3%) had acute HCV and HIV coinfection, 22 (33.3%) had chronic HCV infection and HIV coinfection, and 26 (39.4%) had chronic HCV monoinfection. HCV RNA was detected in semen specimens from 29 of 66 men (43.9%). The median HCV RNA level in blood was 4.0 log IU/mL higher than that in semen. HCV RNA levels were correlated in semen and blood (r(2) = 0.142). Neither HIV positivity nor acute HCV infection was associated with an increased frequency of seminal HCV RNA detection. Among men with acute HCV and HIV coinfection, the median HCV RNA level in blood specimens from those with seminal HCV RNA was higher than that in blood specimens from those without seminal HCV RNA (P = .001). Seminal HCV RNA was detected in ≥1 sample for 26 of 35 men (74.3%) attending follow up. CONCLUSIONS:HCV RNA was detected in semen during both acute and chronic HCV infection. This was unaffected by HIV positivity or the phase of HCV infection. Elevated seminal HCV RNA levels could contribute to sexual transmission of HCV, but other factors, including high-risk behaviors, may be the main drivers for HCV transmission in HIV-infected individuals.
Authors: G V Matthews; S T Pham; M Hellard; J Grebely; L Zhang; A Oon; P Marks; I van Beek; W Rawlinson; J M Kaldor; A Lloyd; G J Dore; P A White Journal: Clin Infect Dis Date: 2011-01-31 Impact factor: 9.079
Authors: Lynn E Taylor; Marisa Holubar; Kunling Wu; Ronald J Bosch; David L Wyles; John A Davis; Kenneth H Mayer; Kenneth E Sherman; Karen T Tashima Journal: Clin Infect Dis Date: 2011-01-31 Impact factor: 9.079
Authors: Joseph A Politch; Kenneth H Mayer; Seth L Welles; William X O'Brien; Chong Xu; Frederick P Bowman; Deborah J Anderson Journal: AIDS Date: 2012-07-31 Impact factor: 4.177
Authors: Thijs J W van de Laar; Akke K van der Bij; Maria Prins; Sylvia M Bruisten; Kees Brinkman; Thomas A Ruys; Jan T M van der Meer; Henry J C de Vries; Jan-Willem Mulder; Michiel van Agtmael; Suzanne Jurriaans; Katja C Wolthers; Roel A Coutinho Journal: J Infect Dis Date: 2007-06-11 Impact factor: 5.226
Authors: Jannie J van der Helm; Maria Prins; Julia del Amo; Heiner C Bucher; Geneviève Chêne; Maria Dorrucci; John Gill; Osamah Hamouda; Mette Sannes; Kholoud Porter; Ronald B Geskus Journal: AIDS Date: 2011-05-15 Impact factor: 4.177
Authors: Cesar Mauricio Rueda; Paula Andrea Velilla; Claire A Chougnet; Carlos Julio Montoya; Maria Teresa Rugeles Journal: PLoS One Date: 2012-01-19 Impact factor: 3.240
Authors: Daniel Bradshaw; Jayna Raghwani; Brendan Jacka; Rachel Sacks-Davis; Francois Lamoury; Ian Down; Garrett Prestage; Tanya L Applegate; Margaret Hellard; Joe Sasadeusz; Gregory J Dore; Oliver G Pybus; Gail V Matthews; Mark Danta Journal: PLoS One Date: 2016-09-01 Impact factor: 3.240
Authors: Bernadien M Nijmeijer; Ramin Sarrami-Forooshani; Gaby S Steba; Renée Rce Schreurs; Sylvie M Koekkoek; Richard Molenkamp; Janke Schinkel; Peter Reiss; Matthijs L Siegenbeek van Heukelom; Marc van der Valk; Carla Ms Ribeiro; Teunis Bh Geijtenbeek Journal: J Int AIDS Soc Date: 2019-03 Impact factor: 5.396
Authors: Sofia R Bartlett; Tanya L Applegate; Brendan P Jacka; Marianne Martinello; Francois Mj Lamoury; Mark Danta; Daniel Bradshaw; David Shaw; Andrew R Lloyd; Margaret Hellard; Gregory J Dore; Gail V Matthews; Jason Grebely Journal: J Int AIDS Soc Date: 2019-02 Impact factor: 5.396
Authors: Thiago A Teixeira; Yasmin C Oliveira; Felipe S Bernardes; Esper G Kallas; Amaro N Duarte-Neto; Sandro C Esteves; Joël R Drevet; Jorge Hallak Journal: Asian J Androl Date: 2021 Jul-Aug Impact factor: 3.285
Authors: Samuel S Turner; Sara Gianella; Marcus J-S Yip; Wouter O van Seggelen; Robert D Gillies; Andrew L Foster; Zachary R Barbati; Davey M Smith; Daniel S Fierer Journal: Open Forum Infect Dis Date: 2016-03-11 Impact factor: 3.835